537 filings
Page 5 of 27
8-K
dmdad5
7 Apr 21
Other Events
5:23pm
424B7
vtk6tdnjnpia
7 Apr 21
Prospectus with selling stockholder info
5:20pm
8-K
8czatmdc4hqkylmudp
24 Mar 21
NeoGenomics Agrees to Acquire Trapelo Health
4:45pm
8-K
o3kqzbs
1 Mar 21
Departure of Directors or Certain Officers
4:45pm
8-K
dm2ufdjjk2 4ds
25 Feb 21
Regulation FD Disclosure
5:08pm
8-K
44r8k7kjbkpgxd
24 Feb 21
NeoGenomics Reports 18% Revenue Growth to $126 Million
7:51am
8-K
wuzil
11 Jan 21
Regulation FD Disclosure
5:16pm
8-K
3ut60v etivzu
11 Jan 21
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
5:13pm
424B5
szmr0dy7popt
8 Jan 21
Prospectus supplement for primary offering
2:17pm
424B5
ofcnsibiicec9q0
8 Jan 21
Prospectus supplement for primary offering
2:15pm
FWP
ktsoaw
7 Jan 21
Free writing prospectus
7:02am
424B5
a2zpl dnr6ef
5 Jan 21
Prospectus supplement for primary offering
4:08pm
S-3ASR
gkquaq3k
5 Jan 21
Automatic shelf registration
4:05pm
8-K
sii7mcf3
5 Jan 21
Other Events
4:01pm
8-K
ywdzkczw9mna1n
29 Oct 20
Regulation FD Disclosure
5:19pm
8-K
ic344p6iaclxenqz1 43
27 Oct 20
NeoGenomics Reports Revenue Growth of 20% to Record $125 Million
7:59am
8-K
m0u zw79yahshbw1
31 Jul 20
INVESTOR PRESENTATION July 2020
5:10pm